Works matching IS 26662345 AND DT 2025 AND VI 8 AND IP 1

Results: 10

Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 47, doi. 10.36401/JIPO-24-22

By:

House, Isabelle;
Valore-Caplan, Mari;
Maris, Elijah;
Falchook, Gerald S.

Publication type:

Article

Oncology Clinical Trials Targeting Members of the Cadherin Superfamily: A Review.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 23, doi. 10.36401/JIPO-24-20

By:

Keeling, Jacob;
Falchook, Gerald

Publication type:

Article

Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 1, doi. 10.36401/JIPO-24-19

By:

Zhuang, Tony Z.;
Goyal, Subir;
Case, Katherine B.;
Olsen, T. Anders;
Vemuru, Shalini;
Yildirim, Ahmet;
Goswamy, Rohit V.;
Brown, Jacqueline T.;
Carthon, Bradley C.;
Kucuk, Omer;
Bilen, Mehmet Asim;
Master, Viraj A.;
Nazha, Bassel

Publication type:

Article

Durable Remission After Targeted Therapy in BRAF V600E--Mutant Metastatic Colorectal Cancer: Case Report.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 11, doi. 10.36401/JIPO-24-16

By:

Fox, Daniel A.;
Bhamidipati, Deepak;
Kopetz, Scott;
Hong, David S.

Publication type:

Article

Expert Clinical Management of Inflammatory Immune-Related Arthritis in Patients with Cancer Receiving Immune Checkpoint Inhibitors.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 64, doi. 10.36401/JIPO-24-15

By:

Bruera, Sebastian;
Riveiro-Barciela, Mar;
Meara, Alexa;
Suarez-Almazor, Maria E.

Publication type:

Article

Usefulness of Comprehensive Genomic Profiling in Clinical Decision-Making in Oncology: A Systematic Review.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 55, doi. 10.36401/JIPO-24-11

By:

Limaye, Sewanti;
Deshmukh, Jayesh;
Rohatagi, Nitesh;
Prabhash, Kumar;
Rauthan, Amit;
Singh, Shambhavi;
Kumar, Arun

Publication type:

Article

Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B Trial.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 82, doi. 10.36401/JIPO-24-10

By:

Gouda, Mohamed A.;
Zarifa, Abdulrazzak;
Yang, Yali;
Stephen, Bettzy;
Gurses, Serdar A.;
Sprenger, Ashabari;
Tian, Yanyan;
Derbala, Mohamed H.;
Oliva, Isabella Glitza;
Meric-Bernstam, Funda;
Patel, Sapna P.

Publication type:

Article

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 71, doi. 10.36401/JIPO-24-8

By:

Naing, Aung;
Mahipal, Amit;
Javle, Milind;
Wang, Judy;
Bauer, Todd M.;
Bajor, David L.;
Elias, Anthony D.;
Shields, Anthony;
Davis, Elizabeth;
Chawla, Sant;
Safran, Howard;
Powderly, John D.;
D'Amato, Gina;
Meyer, Christian F.;
Xiongwen Tang;
Sheng Yao;
Keegan, Patricia

Publication type:

Article

Use of Immunoglobulin Replacement Therapy in Clinical Practice: A Review.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 34, doi. 10.36401/JIPO-24-7

By:

Ahmed, Jibran;
Yeonjoo Choi;
Taeyeong Ko;
Lim, JoAnn;
Hajjar, Joud

Publication type:

Article

A Rare But Fatal Toxicity: Immune Checkpoint Inhibitor--Related Acquired Thrombotic Thrombocytopenic Purpura.

Published in:

Journal of Immunotherapy & Precision Oncology, 2025, v. 8, n. 1, p. 15, doi. 10.36401/JIPO-24-2

By:

Yikilmaz, Aysun Senturk;
Rojas Hernandez, Cristhiam M.

Publication type:

Article